Protein C, human (Ceprotin)
Jump to navigation
Jump to search
Human protein C
History of changes in EMA indication
- 7/16/2001: Initial authorization as Ceprotin
- CEPROTIN is indicated for prophylaxis and treatment of purpura fulminans, coumarin-induced skin necrosis, and venous thrombotic events in patients with severe congenital protein C deficiency.
Also known as
- Brand name: Ceprotin